Lumaxis Trademark Details

Lumaxis was registered on Tuesday, July 31, 2001 and is currently owned by Dupont Pharmaceuticals Company under the registration number 2473855 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 15 years ago on Friday, May 2, 2008, according to the United State Patent & Trademark Office
Word Mark Lumaxis
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Dupont Pharmaceuticals Company of Wilmington, DE

View all trademarks for Dupont Pharmaceuticals Company
Other Trademarks for Dupont Pharmaceuticals Company
Serial Number 75276164
Registration Number 2473855
Status Date Friday, May 2, 2008
Filing Date Friday, May 2, 2008
Registration Date Tuesday, July 31, 2001
Attorney Don M Kerr

Correspondent

G. Mathew Lombard
Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154

Case File Statements

Goods & Services Pharmaceutical Preparations, for the Treatment of Cardiovascular Diseases, Central Nervous System Diseases, Cancer, Inflammation and Inflammatory Diseases, Respiratory and Infectious Diseases and for Diagnostic Imaging

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, May 2, 2008
First Use Anywhere Friday, December 1, 2000
First Use In Commerce Friday, December 1, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.